Argenex SE and Capricor Therapeutics were listed on the Nasdaq stock exchange and are competing in the biotech sector.
2 reports, 1 independent
Updated Sep 12
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Argenex SE and Capricor Therapeutics were listed on the Nasdaq stock exchange and are competing in the biotech sector.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
Related events
- Xenetic Biosciences and XTL Biopharmaceuticals are competing in the small-cap biopharmaceutical space, listed on the Nasdaq stock exchange.
- Jazz Pharmaceuticals and RYTHM are competing in the pharmaceutical market and listed on the Nasdaq stock exchange.
- Connect Biopharma listed its stock on the Nasdaq exchange on August 1, 2026.
- HCW Biologics announced it is listed on the Nasdaq stock exchange.
- Generate Biomedicines Inc listed its shares on the Nasdaq stock exchange on August 25, 2026.